First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Updated on: December 22,2023

First-in-human trial for new lung cancer immunotherapy

byCancer Research UKCancer Research UK and Vaccitech Oncology Limited (VOLT), today (Wednesday) announce a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lu

Updated on:December 22,2023

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Updated on: December 22,2023

Many lung cancer patients receive meds that prolong QTc interval

(HealthDay)—A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval, limiting their eligibility for clinical trials, according to

Updated on:December 22,2023

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer

Updated on: December 20,2023

The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer

byThe Spanish National Cancer Research CentreRAF1. Credit: CNIOOne of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer

Updated on:December 20,2023

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on: December 20,2023

Clinical trial reveals new subtypes of advanced pancreatic cancer

by Ontario Institute for Cancer ResearchDrs. Faiyaz Notta and Steven Gallinger in a laboratory. Credit: OICRResearchers at the Ontario Institute for Cancer Research (OICR) and the University Health Ne

Updated on:December 20,2023

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on: December 25,2023

Basic research opens up new therapeutic opportunities for fighting leukemia

byUniversity of Veterinary Medicine—ViennaGenome-wide CRISPR/Cas9-based loss-of-function screen identifies genetic dependencies of STAT3Y640F-driven cells a) Schematic illustration of a competit

Updated on:December 25,2023

Endocrine disruptors may increase risk of endometrial cancer

by University of GranadaTable full of cosmetic products. Credit: University Of GranadaResearchpublishedin the journalEnvironmental Health Perspectives, has revealed a link betwe

Updated on: March 20,2024

Endocrine disruptors may increase risk of endometrial cancer

by University of GranadaTable full of cosmetic products. Credit: University Of GranadaResearchpublishedin the journalEnvironmental Health Perspectives, has revealed a link betwe

Updated on:March 20,2024

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least

Updated on: October 15,2023

Adjuvant Nivolumab Receives CHMP Recommendation for Completely Resected Stage IIB/C Melanoma

July 21, 2023Chris RyanThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of nivolumab monotherapy for the adjuvant treatment of patients at least

Updated on:October 15,2023

Frailty score may predict outcomes in multiple myeloma

(HealthDay)—A frailty scale that includes Eastern Cooperative Oncology Group performance status (ECOG PS) may predict outcomes for transplant-ineligible patients with newly diagnosed multiple myeloma

Updated on: December 20,2023

Frailty score may predict outcomes in multiple myeloma

(HealthDay)—A frailty scale that includes Eastern Cooperative Oncology Group performance status (ECOG PS) may predict outcomes for transplant-ineligible patients with newly diagnosed multiple myeloma

Updated on:December 20,2023

Strategy could remove metastatic traits and drug resistance from lung cancer cells

byThe Korea Advanced Institute of Science and Technology (KAIST)Figure 1. Construction of the mathematical model of the regulatory network to represent the EMT phenotype based on the interaction

Updated on: December 19,2023

Strategy could remove metastatic traits and drug resistance from lung cancer cells

byThe Korea Advanced Institute of Science and Technology (KAIST)Figure 1. Construction of the mathematical model of the regulatory network to represent the EMT phenotype based on the interaction

Updated on:December 19,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on: December 19,2023

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on:December 19,2023

Slit2 signaling stimulates Ewing sarcoma growth

by Impact Journals LLCEWS::FLI1 binds to the Slit2 gene promoter in Ewing sarcoma cells. Credit: 2022 Suvarna et al.A new research paper was published inGenes & Canceron December 14, 2

Updated on: December 17,2023

Slit2 signaling stimulates Ewing sarcoma growth

by Impact Journals LLCEWS::FLI1 binds to the Slit2 gene promoter in Ewing sarcoma cells. Credit: 2022 Suvarna et al.A new research paper was published inGenes & Canceron December 14, 2

Updated on:December 17,2023

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc

Updated on: April 23,2024

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels, finds study

by Jillian McKoy, Michael Saunders,Boston UniversityCredit: CC0 Public DomainSince August 2018, the US Food & Drug Administration has mandated that all hookah (also known as waterpipe tobacc

Updated on:April 23,2024